Brain Biotechnology Research and Information Network AG (BNNn)

Currency in EUR
2.8900
+0.1300(+4.71%)
Delayed Data·
BNNn is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.76002.8900
52 wk Range
1.95003.8900
Key Statistics
Bid/Ask
2.81 / 2.89
Prev. Close
2.76
Open
2.76
Day's Range
2.76-2.89
52 wk Range
1.95-3.89
Volume
7.72K
Average Volume (3m)
5.66K
1-Year Change
30.7692%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BNNn Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.5000
Upside
+90.31%
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 5.5000
(+90.31% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Deutsche Bank
Buy5.00+73.01%8.00MaintainJan 16, 2026

Earnings

Latest Release
May 28, 2026
EPS / Forecast
-0.16 / --
Revenue / Forecast
11.82M / --
EPS Revisions
Last 90 days

BNNn Income Statement

Compare BNNn to Peers and Sector

Metrics to compare
BNNn
Peers
Sector
Relationship
P/E Ratio
−5.5x13.3x3.6x
PEG Ratio
−0.30−0.210.00
Price/Book
−15.6x1.2x1.6x
Price / LTM Sales
1.2x0.7x1.3x
Upside (Analyst Target)
81.2%28.4%44.4%
Fair Value Upside
Unlock7.5%3.8%Unlock

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.26M5.74%3.45M
Other Institutional Investors
11.40M52.19%31.36M
Public Companies & Retail Investors
9.19M42.07%25.27M
Total
21.85M100.00%60.08M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
MP Beteiligungs-GmbH31.46%6,873,22218,901
Pbg Zweite Gmbh15.10%3,298,9729,072

People Also Watch

33.790
TPEG
+3.33%
95.800
CWCG
-0.83%
71.400
SIXG
-0.35%
11.300
SZUG
-1.91%
41.275
FIEG
-1.14%

FAQ

What Is the Brain (BNNn) Stock Price Today?

The Brain stock price today is 2.8900 EUR.

What Stock Exchange Does Brain Trade On?

Brain is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for Brain?

The stock symbol for Brain is "BNNn."

What Is the Brain Market Cap?

As of today, Brain market cap is 63.1400M EUR.

What Is Brain's Earnings Per Share (TTM)?

The Brain EPS (TTM) is -0.5100.

When Is the Next Brain Earnings Date?

Brain will release its next earnings report on Aug 27, 2026.

From a Technical Analysis Perspective, Is BNNn a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Brain Stock Split?

Brain has split 0 times.

How Many Employees Does Brain Have?

Brain has 280 employees.

What is the current trading status of Brain (BNNn)?

As of Jul 31, 2026, Brain (BNNn) is trading at a price of 2.8900 EUR, with a previous close of 2.7600 EUR. The stock has fluctuated within a day range of 2.7600 EUR to 2.8900 EUR, while its 52-week range spans from 1.9500 EUR to 3.8900 EUR.

What Is Brain (BNNn) Price Target According to Analysts?

The average 12-month price target for Brain is 5.5000 EUR, with a high estimate of 6.5 EUR and a low estimate of 5 EUR. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +90.31% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.